白云山和黄品牌怎么样 申请店铺

我要投票 白云山和黄在医疗器械行业中的票数:332 更新时间:2025-06-30
白云山和黄是哪个国家的品牌?「白云山和黄」是 广州白云山医药集团股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人李楚源在1997-09-01期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力白云山和黄品牌出海!将品牌入驻外推网,定制白云山和黄品牌推广信息,可以显著提高白云山和黄产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

白云山和黄怎么样

始建于1988年,广州白云山医药集团旗下,其板蓝根产品享誉业界,华南地区较大的单体中药生产企业


广州白云山和记黄埔中药有限公司(以下简称“白云山和黄”),由广药集团白云山制药股份有限公司与爱国商人李嘉诚先生旗下和记黄埔(中国)公司于2005年5月合资成立。合资公司前身为广州白云山中药厂,成立于1988年5月,是由1956年组建的农场作业区脱胎而来,并过渡到农工并举的滋补品厂,进而转为经营医药健康事业的广州白云山中药厂。

公司站在时代的前沿和行业的高度,以“教育、爱心、科技、创新、责任”十字方针为指南,以“中药现代化、中药国际化、中药大众化、中药科普化”为使命,以经济效益为中心,内抓管理,外拓市场,实施“人才、品牌、科技”三大战略,形成了科技创新、责任营销、文化传承、人才工程、党建先进五大核心竞争优势。尤其是1999年以来,公司步入高速成长期,实现了跨越式发展。1999年—2013年,企业规模扩大30倍,销售、回款、产值、利润四项指标保持30%以上增长。公司积极打造现代中药先锋企业,向大健康产业优势企业进军。

公司重金打造“神农草堂”中医药博物馆及以神农精神为核心的企业文化,做强文化健康,让更多的人认识、了解和接受中医药。“神农草堂”融知识性、趣味性,集中医药历史、文化及中草药种植于一体,现已接待海内外游客超80万人次,成为雅俗共赏的中医药文化传播典范之作。


Founded in 1988, Guangzhou Baiyunshan Pharmaceutical Group, whose Banlangen products are well-known in the industry, Guangzhou Baiyunshan Hutchison Huangpu traditional Chinese Medicine Co., Ltd. (hereinafter referred to as "Baiyunshan Hutchison"), a large single traditional Chinese medicine manufacturer in South China, was founded in May 2005 by Baiyunshan Pharmaceutical Co., Ltd. of Guangzhou Pharmaceutical group and Hutchison Huangpu (China) Co., Ltd. of patriotic businessman Li Jiacheng Joint venture. The joint venture company, formerly known as Guangzhou Baiyunshan traditional Chinese medicine factory, was founded in May 1988. It was born out of the farm operation area established in 1956, and then transferred to a nourishing factory with both agriculture and industry, and then to Guangzhou Baiyunshan traditional Chinese medicine factory which is engaged in medical and health undertakings. Standing at the forefront of the times and at the height of the industry, guided by the cross policy of "education, love, science and technology, innovation and responsibility", with the mission of "modernization, internationalization, popularization and popularization of traditional Chinese medicine", centering on economic benefits, focusing on internal management, expanding the market and implementing the three strategies of "talent, brand and technology", the company has formed scientific and technological innovation and responsibility Serve as the five core competitive advantages of marketing, cultural heritage, talent engineering and advanced Party construction. Especially since 1999, the company has stepped into a period of rapid growth and achieved leapfrog development. From 1999 to 2013, the scale of the enterprise expanded by 30 times, and the four indicators of sales, payment collection, output value and profit kept growing by more than 30%. The company actively builds a modern Chinese medicine pioneer enterprise, and advances to a large health industry advantage enterprise. The company has invested heavily in building "shennongcaotang" TCM Museum and corporate culture with Shennong spirit as the core to strengthen cultural health and let more people know, understand and accept TCM. "Shennong Caotang" integrates knowledge and interest, focusing on the medical history, culture and planting of Chinese herbal medicine. It has now received more than 800000 tourists at home and abroad, and has become a model of cultural communication of traditional Chinese medicine for both refined and popular tastes.

本文链接: https://brand.waitui.com/1a1b8b398.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

海康威视:加拿大市场在公司2024年营业收入占比中不足0.3%

36氪获悉,海康威视在互动平台表示,加拿大市场在海康威视2024年营业收入占比中不足0.3%,面对各种政治打压,海康威视会继续努力服务好全球客户,继续为加拿大的客户提供产品和服务,会继续坚定推进国际化,会继续提升全球产品竞争力。

6分钟前

商业航天概念持续走高,博亚精工等多股涨停

36氪获悉,截至发稿,商业航天概念持续走高,博亚精工、凯美特气、利君股份、晨曦航空涨停,七丰精工、国科军工、爱乐达、星辰科技、豪能股份、中兵红箭等跟涨。

6分钟前

美国关税冲击下,日本5月工业产出环比仅增0.5%,远逊于预期

周一公布的政府数据显示,日本5月工业产出增速低于预期,因美国全面加征关税威胁到日本本已脆弱的经济复苏。日本经济产业省的数据显示,5月份工业产出环比增长0.5%,远低于3.5%的市场预期中值。日本经济产业省调查的制造商预计,经季节调整后的6月份工业产出将增长0.3%,7月份将下降0.7%。美国关税的打击可能会破坏日本疲弱的经济复苏。(新浪财经)

6分钟前

中信建投:下半年金价不排除会大幅回撤

36氪获悉,中信建投研报表示,1—4月金价大幅上涨至3500美元,核心是特朗普政策带来的不确定性。在下半年贸易缓和、复苏交易的判断下,黄金的短期利多不算明显,若叠加全球股市走强、俄乌冲突缓和等事件,风险偏好回升,在历史高位的金价不排除大幅回撤。

6分钟前

股票型基金新发规模创近四年同期新高

2025年行至年中,截至6月27日,年内已发行成立661只基金(按基金成立日计算),合计发行份额为5261亿份,平均发行份额为7.96亿份,创历史新低。债券基金发行情况不佳,拖累基金整体发行成绩,与之相反的是股票型基金新发规模则创出近四年同期新高。细分类型中,股票型基金有380只,合计发行份额为1855.32亿份,占新发权益基金的近八成;其新发数量、规模同比分别增长66.67%和179.24%,发行规模达到2022年以来同期新高。这主要得益于指数型基金的贡献:上半年成立366只指数基金,总发行份额为1832.03亿份,占据股票型基金新发规模的绝大部分。(中国基金报)

6分钟前

本页详细列出关于白云山和黄的品牌信息,含品牌所属公司介绍,白云山和黄所处行业的品牌地位及优势。
咨询